HomeCompareBGACF vs EQR

BGACF vs EQR: Dividend Comparison 2026

BGACF yields 35714.29% · EQR yields 5.87%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BGACF wins by $1.6752839315172392e+22M in total portfolio value
10 years
BGACF
BGACF
● Live price
35714.29%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.6752839315172392e+22M
Annual income
$16,661,069,746,468,538,000,000,000,000.00
Full BGACF calculator →
EQR
EQR
● Live price
5.87%
Share price
$59.15
Annual div
$3.47
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$47.8K
Annual income
$5,475.61
Full EQR calculator →

Portfolio growth — BGACF vs EQR

📍 BGACF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBGACFEQR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BGACF + EQR cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BGACF pays
EQR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BGACF
Annual income on $10K today (after 15% tax)
$3,035,714.29/yr
After 10yr DRIP, annual income (after tax)
$14,161,909,284,498,257,000,000,000,000.00/yr
EQR
Annual income on $10K today (after 15% tax)
$499.01/yr
After 10yr DRIP, annual income (after tax)
$4,654.27/yr
At 15% tax rate, BGACF beats the other by $14,161,909,284,498,257,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BGACF + EQR for your $10,000?

BGACF: 50%EQR: 50%
100% EQR50/50100% BGACF
Portfolio after 10yr
$8.376419657586196e+21M
Annual income
$8,330,534,873,234,269,000,000,000,000.00/yr
Blended yield
99.45%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

BGACF
No analyst data
Altman Z
-1.8
Piotroski
2/9
EQR
Analyst Ratings
16
Buy
28
Hold
2
Sell
Consensus: Hold
Price Target
$70.35
+18.9% upside vs current
Range: $63.00 — $78.50
Altman Z
1.8
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BGACF buys
0
EQR buys
0
No recent congressional trades found for BGACF or EQR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBGACFEQR
Forward yield35714.29%5.87%
Annual dividend / share$2.00$3.47
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8%
Portfolio after 10y$1.6752839315172392e+22M$47.8K
Annual income after 10y$16,661,069,746,468,538,000,000,000,000.00$5,475.61
Total dividends collected$1.6746806834400388e+22M$23.0K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: BGACF vs EQR ($10,000, DRIP)

YearBGACF PortfolioBGACF Income/yrEQR PortfolioEQR Income/yrGap
1← crossover$3,582,129$3,571,428.57$11,380$679.82+$3.57MBGACF
2$1,199,469,917$1,195,637,039.86$13,014$837.25+$1199.46MBGACF
3$375,448,961,128$374,165,528,316.29$14,961$1,036.20+$375448.95MBGACF
4$109,858,226,763,271$109,456,496,374,863.77$17,297$1,289.22+$109858226.75MBGACF
5$30,049,803,731,826,150$29,932,255,429,189,452.00$20,121$1,613.15+$30049803731.81MBGACF
6$7,683,972,846,060,485,000$7,651,819,556,067,430,000.00$23,561$2,030.84+$7683972846060.46MBGACF
7$1,836,848,834,513,013,000,000$1,828,626,983,567,728,800,000.00$27,783$2,573.54+$1836848834513013.00MBGACF
8$410,500,120,243,639,900,000,000$408,534,691,990,711,000,000,000.00$33,013$3,284.39+$410500120243639936.00MBGACF
9$85,765,952,059,675,500,000,000,000$85,326,716,931,014,800,000,000,000.00$39,547$4,223.51+$85765952059675492352.00MBGACF
10$16,752,839,315,172,392,000,000,000,000$16,661,069,746,468,538,000,000,000,000.00$47,791$5,475.61+$1.6752839315172392e+22MBGACF

BGACF vs EQR: Complete Analysis 2026

BGACFStock

BioNeutra Global Corporation, together with its subsidiaries, engages in the research and development, production, and commercialization of food ingredients for nutraceutical, functional, and mainstream foods, and beverages with a focus on oligosaccharides. The company's lead product is VitaFiber, an isomalto-oligosaccharide functional and health food ingredient that offers low calorie soluble prebiotic fiber for human digestive health. It serves small and medium enterprises, and various food manufacturers in in Canada, the United States, Europe, Australia, New Zealand, and Southeast Asia. The company provides VitaFiber through Amazon.com and Shopify.com, as well as other direct-to-consumer retail channels. BioNeutra Global Corporation is based in Edmonton, Canada.

Full BGACF Calculator →

EQRREIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →
📬

Get this BGACF vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BGACF vs SCHDBGACF vs JEPIBGACF vs OBGACF vs KOBGACF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.